Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.27
+0.52 (6.71%)
At close: Sep 26, 2025, 4:00 PM EDT
8.31
+0.04 (0.48%)
After-hours: Sep 26, 2025, 7:58 PM EDT
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$866,977
Profits / Employee
-$168,837
Market Cap
607.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARVN News
- 10 days ago - Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party - Reuters
- 10 days ago - Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation - GlobeNewsWire
- 18 days ago - Arvinas, Inc. (ARVN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer - GlobeNewsWire
- 7 weeks ago - Arvinas, Inc. (ARVN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire